Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zahid Rafiq

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Genes & Diseases|September 28, 2018
Role of autophagy and histone deacetylases in diabetic nephropathy: Current status and future perspectivesSabbir Khan, Zahid Rafiq Bhat, Gopabandhu Jena
Scientific Reports|October 22, 2020
MicroRNA-941 regulates the proliferation of breast cancer cells by altering histone H3 Ser 10 phosphorylationSunil Kumar Surapaneni, Zahid Rafiq Bhat, Kulbhushan Tikoo
ACS Pharmacology & Translational Science|October 16, 2025
Integrating AI, Machine Learning, and Animal Models for Precision Oncology: Bridging Preclinical and Clinical GapsZahid Rafiq, Tanzeel Bashir, Weiqin Lu, et al.
In Silico Pharmacology|August 14, 2023
Target validation and structure-based virtual screening to Discover potential lead molecules against the oncogenic NSD1 histone methyltransferaseZahid Rafiq Bhat, Anuj Gahlawat, Navneet Kumar, et al.
AAPS Pharmscitech|July 11, 2024
HSPiP, Computational, and Thermodynamic Model-Based Optimized Solvents for Subcutaneous Delivery of Tolterodine Tartrate and GastroPlus‑Based In Vivo Prediction in Humans: Part IITasneem Khan, Afzal Hussain, Mohd Usman Mohd Siddique, et al.
AAPS Pharmscitech|May 1, 2024
HSPiP, Computational, and Thermodynamic Model-Based Optimized Solvents for Subcutaneous Delivery of Tolterodine Tartrate and GastroPlus-Based In Vivo Prediction in Humans: Part IAbdul Malik, Tasneem Khan, Mohd Usman Mohd Siddique, et al.
Molecules (Basel, Switzerland)|April 3, 2021
Design and Synthesis of Non-Covalent Imidazo[1,2-<i>a</i>]quinoxaline-Based Inhibitors of EGFR and Their Anti-Cancer AssessmentManvendra Kumar, Gaurav Joshi, Sahil Arora, et al.
Bioorganic Chemistry|May 1, 2020
Synthesis and evaluation of new 1,2,4-oxadiazole based trans- acrylic acid derivatives as potential PPAR-alpha/gamma dual agonistParanjeet Kaur, Zahid Rafiq Bhat, Sana Bhat, et al.
Molecules (Basel, Switzerland)|September 9, 2022
In Vivo Anticancer Evaluation of 6b, a Non-Covalent Imidazo[1,2-<i>a</i>]quinoxaline-Based Epidermal Growth Factor Receptor Inhibitor against Human Xenograft Tumor in Nude MiceZahid Rafiq Bhat, Manvendra Kumar, Nisha Sharma, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 29, 2025
Enhancing immunotherapy efficacy with synergistic low-dose radiation in metastatic melanoma: current insights and prospectsZahid Rafiq, Mingyo Kang, Hampartsoum B Barsoumian, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Genes & Diseases|September 28, 2018
Role of autophagy and histone deacetylases in diabetic nephropathy: Current status and future perspectivesSabbir Khan, Zahid Rafiq Bhat, Gopabandhu Jena
Scientific Reports|October 22, 2020
MicroRNA-941 regulates the proliferation of breast cancer cells by altering histone H3 Ser 10 phosphorylationSunil Kumar Surapaneni, Zahid Rafiq Bhat, Kulbhushan Tikoo
ACS Pharmacology & Translational Science|October 16, 2025
Integrating AI, Machine Learning, and Animal Models for Precision Oncology: Bridging Preclinical and Clinical GapsZahid Rafiq, Tanzeel Bashir, Weiqin Lu, et al.
In Silico Pharmacology|August 14, 2023
Target validation and structure-based virtual screening to Discover potential lead molecules against the oncogenic NSD1 histone methyltransferaseZahid Rafiq Bhat, Anuj Gahlawat, Navneet Kumar, et al.
AAPS Pharmscitech|July 11, 2024
HSPiP, Computational, and Thermodynamic Model-Based Optimized Solvents for Subcutaneous Delivery of Tolterodine Tartrate and GastroPlus‑Based In Vivo Prediction in Humans: Part IITasneem Khan, Afzal Hussain, Mohd Usman Mohd Siddique, et al.
AAPS Pharmscitech|May 1, 2024
HSPiP, Computational, and Thermodynamic Model-Based Optimized Solvents for Subcutaneous Delivery of Tolterodine Tartrate and GastroPlus-Based In Vivo Prediction in Humans: Part IAbdul Malik, Tasneem Khan, Mohd Usman Mohd Siddique, et al.
Molecules (Basel, Switzerland)|April 3, 2021
Design and Synthesis of Non-Covalent Imidazo[1,2-<i>a</i>]quinoxaline-Based Inhibitors of EGFR and Their Anti-Cancer AssessmentManvendra Kumar, Gaurav Joshi, Sahil Arora, et al.
Bioorganic Chemistry|May 1, 2020
Synthesis and evaluation of new 1,2,4-oxadiazole based trans- acrylic acid derivatives as potential PPAR-alpha/gamma dual agonistParanjeet Kaur, Zahid Rafiq Bhat, Sana Bhat, et al.
Molecules (Basel, Switzerland)|September 9, 2022
In Vivo Anticancer Evaluation of 6b, a Non-Covalent Imidazo[1,2-<i>a</i>]quinoxaline-Based Epidermal Growth Factor Receptor Inhibitor against Human Xenograft Tumor in Nude MiceZahid Rafiq Bhat, Manvendra Kumar, Nisha Sharma, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 29, 2025
Enhancing immunotherapy efficacy with synergistic low-dose radiation in metastatic melanoma: current insights and prospectsZahid Rafiq, Mingyo Kang, Hampartsoum B Barsoumian, et al.
Pageof 2